Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review.

Edith A PerezChau DangCaleb LeeJasmeet SinghKongming WangJ Bradley LaytonAlicia GilsenanMichelle D HackshawJavier Cortes

Published in: Breast cancer research and treatment (2022)

Differing AE profiles for anti-HER2 therapies should be considered when assessing benefit-risk profile for treatment options.

Keyphrases